Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01072877 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety Study of Polidocanol Injectable Foam for the Treatment of Saphenofemoral Junction (SFJ) Incompetence
A Phase 3 study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 279
- Enrollment target
NCT01072877 is a Phase 3 study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 279 participants.
The verdict
NCT01072877, a Phase 3 study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 279 participants
- Enrollment target
Study Summary
Varicose veins are enlarged, noticeably bulging veins, which commonly occur in the legs and may cause discomfort. In this study, patients with varicose veins in the legs will be participating. The purpose of this research study is to evaluate the safety and effectiveness of three different concentrations of an investigational drug, polidocanol injectable foam compared to vehicle (inactive solution) in treating the symptoms and appearance of varicose veins.
Interventions
- DRUG Polidocanol injectable foam (PEM)
- DRUG Placebo Vehicle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 279 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01072877
The ClinicalTrials.gov registry entry for NCT01072877 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 279 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Polidocanol injectable foam (PEM) is the first listed.
NCT01072877 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01072877 about?
NCT01072877 is a clinical study titled "Efficacy and Safety Study of Polidocanol Injectable Foam for the Treatment of Saphenofemoral Junction (SFJ) Incompetence". Varicose veins are enlarged, noticeably bulging veins, which commonly occur in the legs and may cause discomfort. In this study, patients with varicose veins in the legs will be participating. The purpose of this research study is to evaluate the safety and effectiveness of three different concentra...
What is the current status of trial NCT01072877?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 279 participants. The study started on 2010-12. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01072877?
The interventions under investigation include: Polidocanol injectable foam (PEM) (DRUG), Placebo Vehicle (DRUG).
Who is sponsoring clinical trial NCT01072877?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.